Thus, reduced levels of APOM, with its antioxidant, endothelium-protective, and antiatherogenic properties,15,16,37 may contribute to the increased susceptibility to atherosclerosis seen in patients with CKD. The gene discussed is APOM; the disease is chronic kidney disease.